Related Experiment Video
Updated: Oct 12, 2025
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Simultaneous transcatheter intervention for atrial septal defect complicated with patent ductus arteriosus: A 13-year
Qiguang Wang1, Xianyang Zhu1, Zhongchao Wang1
1Department of Congenital Heart Disease, General Hospital of Shenyang Military Command, Shenyang, Liaoning 110016, China.
Insights
Simultaneous transcatheter intervention for atrial septal defect (ASD) and patent ductus arteriosus (PDA) is feasible and effective. This approach demonstrated a 100% success rate with no severe complications in 22 patients.
Area of Science:
- Cardiovascular Interventions
- Congenital Heart Disease Treatment
- Percutaneous Procedures
Background:
- Atrial septal defect (ASD) and patent ductus arteriosus (PDA) are common congenital heart conditions.
- Concurrent ASD and PDA often require complex management strategies.
- The efficacy of simultaneous transcatheter closure for combined ASD and PDA has not been systematically evaluated.
Observation:
- A retrospective analysis included 22 patients with concurrent ASD and PDA.
- All patients underwent simultaneous transcatheter interventional therapy.
- Follow-up was conducted for at least 6 months post-procedure.
Findings:
- The simultaneous transcatheter intervention achieved a 100% success rate.
- No severe complications were observed during the procedures or follow-up period.
- This indicates a high safety and efficacy profile for the combined intervention.
Implications:
- Simultaneous transcatheter closure is a viable and effective treatment option for patients with combined ASD and PDA.
- This approach may offer a streamlined and less invasive treatment pathway.
- Further research can explore long-term outcomes and expand patient selection criteria.
Abstract:
Purpose: The feasibility and validity of simultaneous transcatheter interventions for patients with atrial septal defect (ASD) complicated with patent ductus arteriosus (PDA) has not been systematically evaluated. Materials and Methods: A retrospective analysis was conducted in patients who received transcatheter procedures for ASD complicated with PDA concurrently. The indications and treatment protocols were in accordance with the current guidelines. The sequence of therapy for ASD complicated with PDA was determined by clinical experience. Patients were followed up for at least 6 months after therapy Results: Overall, 22 patients received simultaneous transcatheter interventional therapy, and the success rate was a 100%. No severe complications transpired during the procedure or follow-up stage. Conclusion: Simultaneous transcatheter intervention is feasible and effective for patients who have concurrent complications for both ASD and PDA.
